Administration of non-oral androgenic steroids to women
AssigneeActavis, Inc.
InventorsTheresa Rosario-Jansen, Norman Mazer
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions, methods, and kits for improving health in a woman having elevated SHBG levels, or who is receiving oral estrogen supplementation, by non-orally administering an effective amount of an androgenic steroid. Further, the present invention provides compositions, methods, and kits for coadministering an effective amount of an orally administered estrogen and an effective amount of a non-orally administered androgenic steroid for women in need of estrogen supplementation.
Claims27
A method of improving health in a woman having an elevated or substantially elevated level of sex hormone binding globulin (SHBG) comprising non-orally administering to said woman testosterone in an amount sufficient to provide a therapeutic effect in the presence of elevated or substantially elevated SHBG levels, wherein the improved health is manifest by restoration, enhancement, or improvement of a characteristic selected from the group consisting of sexual desire, stimulation to sexual organs, ability to achieve orgasm, pleasure in sexual activity, and frequency of sexual activity.
A method of improving health in a woman having an elevated or substantially elevated level of sex hormone binding globulin (SHBG) comprising non-orally administering to said woman testosterone in an amount sufficient to provide a therapeutic effect in the presence of elevated or substantially elevated SHBG levels, wherein the improved health is manifest by restoration, enhancement, or improvement of sexual desire.
Dependencies are inferred from the claim text.